Valuation: Repligen Corporation

Market Cap 8.3B 7.21B 6.73B 6.18B 11.66B 791B 11.86B 79.4B 31.1B 394B 31.17B 30.48B 1,301B P/E 2026 *
188x
P/E 2027 * 83.5x
Enterprise Value 8.1B 7.04B 6.58B 6.04B 11.38B 773B 11.58B 77.54B 30.37B 385B 30.44B 29.77B 1,271B EV / Sales 2026 *
9.8x
EV / Sales 2027 * 8.17x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+0.10%
1 week+0.25%
Current month+3.33%
1 month+3.00%
3 months+23.26%
6 months-0.28%
Current year-11.08%
1 week 139.4
Extreme 139.3975
149.73
1 month 129
Extreme 129
154
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
16/7/26 Sell

Chief Financial Officer

-530 0.0009%
25/6/26 Sell

Chief Financial Officer

-733 0.0013%
14/5/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.10%+0.25%+25.07%-15.69% 8.3B
-1.17%-1.39%-18.59%-1.74% 185B
-0.86%-1.28%-4.32%+2.06% 111B
-1.12%-4.70%+3.72%+64.33% 60B
+2.63%+4.85%+48.14%+59.49% 53.9B
-0.04%+2.06%-5.11%-37.31% 46.9B
+1.49%+1.23% - - 34.22B
-0.31%+15.77%+13.65%-27.99% 32.95B
-0.38%+2.34%+44.67%-8.05% 24.49B
+0.16%+0.85%+1.69%+2.78% 22.67B
Average +0.09%+5.87%+12.10%+4.21% 57.97B
Weighted average by Cap. -0.30%+3.89%+0.81%+7.40%

Financials

2026 *2027 *
Net sales 827M 719M 671M 616M 1.16B 78.83B 1.18B 7.91B 3.1B 39.31B 3.11B 3.04B 130B 969M 842M 786M 722M 1.36B 92.38B 1.39B 9.27B 3.63B 46.07B 3.64B 3.56B 152B
Net income 43.45M 37.77M 35.26M 32.37M 61.03M 4.14B 62.1M 416M 163M 2.07B 163M 160M 6.81B 101M 87.73M 81.9M 75.19M 142M 9.62B 144M 966M 378M 4.8B 379M 371M 15.83B
Net Debt -195M -169M -158M -145M -274M -18.56B -278M -1.86B -730M -9.26B -732M -715M -30.53B -379M -329M -307M -282M -532M -36.08B -541M -3.62B -1.42B -17.99B -1.42B -1.39B -59.35B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
05/08/26 USD 145.69 -0.93% 268,407
03/08/26 USD 147.06 +4.29% 1,010,517
31/07/26 USD 141.01 -1.80% 875,270
30/07/26 USD 143.60 +1.68% 1,042,805
29/07/26 USD 141.23 -2.83% 1,514,030
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
147.06USD
Average target price
185.70USD
Spread / Average Target
+26.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock